1. Home
  2. MERC vs XTNT Comparison

MERC vs XTNT Comparison

Compare MERC & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mercer International Inc.

MERC

Mercer International Inc.

HOLD

Current Price

$1.26

Market Cap

106.5M

ML Signal

HOLD

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

HOLD

Current Price

$0.58

Market Cap

88.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MERC
XTNT
Founded
1968
N/A
Country
Canada
United States
Employees
N/A
N/A
Industry
Paper
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.5M
88.7M
IPO Year
2005
2009

Fundamental Metrics

Financial Performance
Metric
MERC
XTNT
Price
$1.26
$0.58
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$2.50
$1.50
AVG Volume (30 Days)
374.2K
99.1K
Earning Date
04-30-2026
03-06-2026
Dividend Yield
11.54%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$1,169,145,000.00
$53,337,000.00
Revenue This Year
$13.75
$15.08
Revenue Next Year
$10.12
N/A
P/E Ratio
N/A
$19.34
Revenue Growth
25.50
N/A
52 Week Low
$1.27
$0.34
52 Week High
$6.78
$0.95

Technical Indicators

Market Signals
Indicator
MERC
XTNT
Relative Strength Index (RSI) 22.96 47.83
Support Level N/A $0.55
Resistance Level $2.30 $0.68
Average True Range (ATR) 0.10 0.05
MACD -0.04 -0.00
Stochastic Oscillator 4.31 26.21

Price Performance

Historical Comparison
MERC
XTNT

About MERC Mercer International Inc.

Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

Share on Social Networks: